Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

Lumican promotes calcific aortic valve disease through H3 histone lactylation

Abstract

BACKGROUND AND AIMS: Valve interstitial cells (VICs) undergo a transition to intermediate state cells before ultimately transforming into the osteogenic cell population, which is a pivotal cellular process in calcific aortic valve disease (CAVD). Herein, this study successfully delineated the stages of VIC osteogenic transformation and elucidated a novel key regulatory role of lumican (LUM) in this process. METHODS: Single-cell RNA-sequencing (scRNA-seq) from nine human aortic valves was used to characterize the pathological switch process and identify key regulatory factors. The in vitro, ex vivo, in vivo, and double knockout mice were constructed to further unravel the calcification-promoting effect of LUM. Moreover, the multi-omic approaches were employed to analyse the molecular mechanism of LUM in CAVD. RESULTS: ScRNA-seq successfully delineated the process of VIC pathological transformation and highlighted the significance of LUM as a novel molecule in this process. The pro-calcification role of LUM is confirmed on the in vitro, ex vivo, in vivo level, and ApoE-/-//LUM-/- double knockout mice. The LUM induces osteogenesis in VICs via activation of inflammatory pathways and augmentation of cellular glycolysis, resulting in the accumulation of lactate. Subsequent investigation has unveiled a novel LUM driving histone modification, lactylation, which plays a role in facilitating valve calcification. More importantly, this study has identified two specific sites of histone lactylation, namely, H3K14la and H3K9la, which have been found to facilitate the process of calcification. The confirmation of these modification sites' association with the expression of calcific genes Runx2 and BMP2 has been achieved through ChIP-PCR analysis. CONCLUSIONS: The study presents novel findings, being the first to establish the involvement of lumican in mediating H3 histone lactylation, thus facilitating the development of aortic valve calcification. Consequently, lumican would be a promising therapeutic target for intervention in the treatment of CAVD.

Overview

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehae407

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 61 references

Cited by

See all 124

Metadata

Authors
Huang, Y., Wang, C., Zhou, T., Xie, F., Liu, Z., Xu, H., Liu, M., Wang, S., Li, L., Chi, Q., Shi, J., Dong, N., & Xu, K.
Affiliations
  • Wuhan Union Hospital (CN)
  • Hubei University of Chinese Medicine (CN)
  • First Affiliated Hospital of Zhengzhou University (CN)
  • Wuhan University of Technology (CN)
Corresponding author
  • Wang, Chunli
  • Shi, Jiawei
  • Dong, Nianguo
  • Xu, Kang
Venue
European Heart Journal
Published
2024-07-08
Volume
45
Issue
37
Pages
3871-3885
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W4400414483
Cited by
124
References
61
Citations by year
2026: 35 · 2025: 58 · 2024: 31
FWCI
37.11
Type
journal article
Language
en
Open access
closed
Locations
  • European Heart Journal (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (82204659, 82300413, 82200410, 82370379, 82300416)
  • Jiangsu Provincial Basic Research Program Natural Science Foundation Youth Fund Project (BK20230732)
  • Young Talent Elite Scientists Sponsorship Program of China Association of Chinese Medicine (CACM-2023-QNRC2-B06)
  • China Postdoctoral Science Foundation (2022M721263)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Bone and Dental Protein Studies
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Keywords
lumican, calcific aortic valve disease, valvular interstitial cells, histone lactylation, histone modifications, Runx2, BMP-2, lactate accumulation, inflammation, aortic valve calcification, therapeutic target
MeSH terms
Lumican, Animals, Aortic Valve, Aortic Valve Stenosis, Calcinosis, Histones, Humans, Male, Osteogenesis, Mice, Knockout, Core Binding Factor Alpha 1 Subunit, Mice, Bone Morphogenetic Protein 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lumican promotes calcific aortic valve disease through H3 histone lactylation. https://app.cochat.ai/papers/10.1093/eurheartj/ehae407
The paper
Huang, Y., Wang, C., Zhou, T., Xie, F., Liu, Z., Xu, H., Liu, M., Wang, S., Li, L., Chi, Q., Shi, J., Dong, N., & Xu, K. (2024). Lumican promotes calcific aortic valve disease through H3 histone lactylation. European Heart Journal. https://doi.org/10.1093/eurheartj/ehae407

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.